Gernot Engstler Selected Research

Inotuzumab Ozogamicin

1/2024	Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22+ acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial.
1/2022	Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gernot Engstler Research Topics

Disease

4	Neoplasms (Cancer) 03/2024 - 01/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 03/2024
1	Residual Neoplasm 12/2023
1	Fever (Fevers) 01/2021
1	Leukemia 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Viremia 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Appendicitis 01/2021

Drug/Important Bio-Agent (IBA)

2	Inotuzumab OzogamicinIBA 01/2024 - 01/2022
1	Mitotane (Lysodren)FDA Link 03/2024
1	GlucocorticoidsIBA 03/2024
1	pegaspargase (Oncaspar)FDA Link 12/2023
1	CalicheamicinsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	ChromatinIBA 01/2021

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2024 - 01/2021
1	Therapeutics 03/2024
1	Appendectomy 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Stem Cell Transplantation 01/2021